Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation April 28, 2022
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting April 25, 2022
Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs April 21, 2022
Insmed to Host First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022 April 21, 2022
RECOVERY CENTERS OF AMERICA AND MAPDA (MOTHERS AGAINST PRESCRIPTION DRUG ABUSE) 2022 SCHOLARSHIP WINNERS COMMITTED TO THE FIGHT AGAINST ADDICTION April 20, 2022
Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health April 20, 2022
Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting April 18, 2022
